Cargando…

The oncogenic roles of JC polyomavirus in cancer

JC polyomavirus (JCPyV) belongs to the human polyomavirus family. Based on alternative splicing, the early region encodes the large and small T antigens, while the late region encodes the capsid structural proteins (VP1, VP2, and VP3) and the agnoprotein. The regulatory transcription factors for JCP...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hua-chuan, Xue, Hang, Zhang, Cong-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537617/
https://www.ncbi.nlm.nih.gov/pubmed/36212474
http://dx.doi.org/10.3389/fonc.2022.976577
_version_ 1784803244175785984
author Zheng, Hua-chuan
Xue, Hang
Zhang, Cong-yu
author_facet Zheng, Hua-chuan
Xue, Hang
Zhang, Cong-yu
author_sort Zheng, Hua-chuan
collection PubMed
description JC polyomavirus (JCPyV) belongs to the human polyomavirus family. Based on alternative splicing, the early region encodes the large and small T antigens, while the late region encodes the capsid structural proteins (VP1, VP2, and VP3) and the agnoprotein. The regulatory transcription factors for JCPyV include Sp1, TCF-4, DDX1, YB-1, LCP-1, Purα, GF-1, and NF-1. JCPyV enters tonsillar tissue through the intake of raw sewage, inhalation of air droplets, or parent-to-child transmission. It persists quiescently in lymphoid and renal tissues during latency. Both TGF-β1 and TNF-α stimulates JCPyV multiplication, while interferon-γ suppresses the process. The distinct distribution of caspid receptors (α-2, 6-linked sialic acid, non-sialylated glycosaminoglycans, and serotonin) determines the infection capabilities of JCPyV virions, and JCPyV entry is mediated by clathrin-mediated endocytosis. In permissive cells, JCPyV undergoes lytic proliferation and causes progressive multifocal leukoencephalopathy, while its DNA is inserted into genomic DNA and leads to carcinogenesis in non-permissive cells. T antigen targets p53, β-catenin, IRS, Rb, TGF-β1, PI3K/Akt and AMPK signal pathways in cancer cells. Intracranial injection of T antigen into animals results in neural tumors, and transgenic mice develop neural tumors, lens tumor, breast cancer, gastric, Vater’s, colorectal and pancreatic cancers, insulinoma, and hepatocellular carcinoma. Additionally, JCPyV DNA and its encoded products can be detected in the brain tissues of PML patients and brain, oral, esophageal, gastric, colorectal, breast, cervical, pancreatic, and hepatocellular cancer tissues. Therefore, JCPyV might represent an etiological risk factor for carcinogenesis and should be evaluated for early prevention, diagnosis, and treatment of cancers.
format Online
Article
Text
id pubmed-9537617
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95376172022-10-08 The oncogenic roles of JC polyomavirus in cancer Zheng, Hua-chuan Xue, Hang Zhang, Cong-yu Front Oncol Oncology JC polyomavirus (JCPyV) belongs to the human polyomavirus family. Based on alternative splicing, the early region encodes the large and small T antigens, while the late region encodes the capsid structural proteins (VP1, VP2, and VP3) and the agnoprotein. The regulatory transcription factors for JCPyV include Sp1, TCF-4, DDX1, YB-1, LCP-1, Purα, GF-1, and NF-1. JCPyV enters tonsillar tissue through the intake of raw sewage, inhalation of air droplets, or parent-to-child transmission. It persists quiescently in lymphoid and renal tissues during latency. Both TGF-β1 and TNF-α stimulates JCPyV multiplication, while interferon-γ suppresses the process. The distinct distribution of caspid receptors (α-2, 6-linked sialic acid, non-sialylated glycosaminoglycans, and serotonin) determines the infection capabilities of JCPyV virions, and JCPyV entry is mediated by clathrin-mediated endocytosis. In permissive cells, JCPyV undergoes lytic proliferation and causes progressive multifocal leukoencephalopathy, while its DNA is inserted into genomic DNA and leads to carcinogenesis in non-permissive cells. T antigen targets p53, β-catenin, IRS, Rb, TGF-β1, PI3K/Akt and AMPK signal pathways in cancer cells. Intracranial injection of T antigen into animals results in neural tumors, and transgenic mice develop neural tumors, lens tumor, breast cancer, gastric, Vater’s, colorectal and pancreatic cancers, insulinoma, and hepatocellular carcinoma. Additionally, JCPyV DNA and its encoded products can be detected in the brain tissues of PML patients and brain, oral, esophageal, gastric, colorectal, breast, cervical, pancreatic, and hepatocellular cancer tissues. Therefore, JCPyV might represent an etiological risk factor for carcinogenesis and should be evaluated for early prevention, diagnosis, and treatment of cancers. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9537617/ /pubmed/36212474 http://dx.doi.org/10.3389/fonc.2022.976577 Text en Copyright © 2022 Zheng, Xue and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zheng, Hua-chuan
Xue, Hang
Zhang, Cong-yu
The oncogenic roles of JC polyomavirus in cancer
title The oncogenic roles of JC polyomavirus in cancer
title_full The oncogenic roles of JC polyomavirus in cancer
title_fullStr The oncogenic roles of JC polyomavirus in cancer
title_full_unstemmed The oncogenic roles of JC polyomavirus in cancer
title_short The oncogenic roles of JC polyomavirus in cancer
title_sort oncogenic roles of jc polyomavirus in cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537617/
https://www.ncbi.nlm.nih.gov/pubmed/36212474
http://dx.doi.org/10.3389/fonc.2022.976577
work_keys_str_mv AT zhenghuachuan theoncogenicrolesofjcpolyomavirusincancer
AT xuehang theoncogenicrolesofjcpolyomavirusincancer
AT zhangcongyu theoncogenicrolesofjcpolyomavirusincancer
AT zhenghuachuan oncogenicrolesofjcpolyomavirusincancer
AT xuehang oncogenicrolesofjcpolyomavirusincancer
AT zhangcongyu oncogenicrolesofjcpolyomavirusincancer